4 news items
GSK, Boston Beer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
AVXL
BWLP
CMPS
3 Jun 24
as an independent company and our return to growth," the company said.
Anavex Life Sciences Corp
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
SAVA
10 May 24
of independent clinical research experts who periodically review interim patient safety data. Routine, scheduled DSMB meetings were held September 2023
Cassava Sciences Completes Interim Safety Review Of Oral Simufilam On-Going Phase 3 Trials
SAVA
25 Mar 24
An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufilam
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
SAVA
25 Mar 24
An Independent
- Prev
- 1
- Next